drugset / Trial / NCT01370187

Montelukast for Acute Bronchiolitis and Postbronchiolitis Viral Induced Wheezing

NCT01370187

RandomizedParallel-groupSingle-blindTreatment

Summary

The aim of the current study is to evaluate the effect of Montelukast in treatment of acute bronchiolitis and postbronchiolitis viral induced wheezing of infants 3 to 12 months of age in Bandar Abbas Children' hospital.

Timeline

Start
2010-07
Primary completion
2011-04
Completion
2011-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Montelukast Other / unclassified 4 mg